{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:26:42Z","timestamp":1791052002247,"version":"4.1.0"},"reference-count":22,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T00:00:00Z","timestamp":1230508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> The impact of highly active antiretroviral therapy (HAART) on progression to end\u2010stage liver disease (ESLD) in human immunodeficiency virus (HIV)\/hepatitis C virus (HCV) co\u2010infection remains controversial. We studied 157 HCV+ haemophilic men (85 HIV+ and 72 HIV\u2212), on whom dates of HIV and HCV seroconversion and clinical outcomes were known. Time to ESLD was determined by Kaplan\u2013Meier product\u2010limit methods and risk factors for ESLD progression were analysed by a Cox proportional hazards model. Among HIV+ men, ESLD was more common, 17 of 85 (20.0%) than in HIV\u2212, eight of 72 (11.1%) and median ESLD\u2010free survival significantly shorter, <jats:italic>P<\/jats:italic>\u2003=\u20030.009, hazard ratio 3.00 [95% confidence interval (CI): 1.27\u20137.08]. HAART treated HIV+ had longer ESLD\u2010free survival than HIV+ untreated, 30.3 vs. 20.0\u2003years, <jats:italic>P<\/jats:italic>\u2003=\u20030.043, hazard ratio, 3.14 (95% CI: 1.27\u20137.08), comparable with survival in HIV\u2212 men, <jats:italic>P<\/jats:italic>\u2003=\u20030.13, hazard ratio 2.20 (95% CI: 0.76\u20132.35). Progression was unrelated to HAART toxicity (<jats:italic>n<\/jats:italic>\u2003=\u20030) or HCV antiviral therapy (<jats:italic>n<\/jats:italic>\u2003=\u20037). HIV+ HAART Rx and HIV\u2212 did not differ in HCV duration, age at ESLD, age at death or present, overall or AIDS mortality, all <jats:italic>P<\/jats:italic>\u2003&gt;\u20030.05. These data suggest that HAART improves ESLD\u2010free survival, approaching that in HIV\u2212 men.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2008.01935.x","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T17:31:28Z","timestamp":1230744688000},"page":"552-558","source":"Crossref","is-referenced-by-count":34,"title":["Highly active antiretroviral therapy improves ESLD\u2010free survival in HIV\u2010HCV co\u2010infection"],"prefix":"10.1111","volume":"15","author":[{"given":"M. V.","family":"RAGNI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"NALESNIK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"SCHILLO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"DANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,3,23]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/319273"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/321909"},{"key":"e_1_2_7_4_2","first-page":"1584","article-title":"End\u2010stage liver disease in persons with hemophilia and transfusion\u2010associated infections","volume":"100","author":"Goedert JJ","year":"2002","journal-title":"Blood"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20541"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14844-1"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/381453"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.26517"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/499055"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.07.006"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg071"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl280"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2006.05.002"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000163935.99401.25"},{"key":"e_1_2_7_16_2","first-page":"613","article-title":"Effects of hepatitis C virus co\u2010infection on survival in veterans with HIV treated with highly active antiretroviral therapy","volume":"39","author":"Backus L","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.017"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1972.03200180052024"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/315143"},{"key":"e_1_2_7_20_2","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V106.11.319.319","article-title":"Predictors of liver fibrosis in HCV(+) hemophilic men","volume":"106","author":"Soadwa K","year":"2005","journal-title":"Blood"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"e_1_2_7_22_2","first-page":"2563","article-title":"Immunosuppression may lead to progression of hepatitis C virus\u2010associated liver disease in hemophiliacs co\u2010infected with HIV","volume":"91","author":"Rockstroh JK","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/379254"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2008.01935.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2008.01935.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:35:15Z","timestamp":1697355315000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2008.01935.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-2516.2008.01935.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2008.01935.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}